Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genetic liability to bipolar disorder and body mass index: A bidirectional two-sample mendelian randomization study

Lars Meinertz Byg, View ORCID ProfileMaria Speed, View ORCID ProfileDoug Speed, View ORCID ProfileSøren Dinesen Østergaard
doi: https://doi.org/10.1101/2022.01.31.22270154
Lars Meinertz Byg
1Department of Affective Disorders, Aarhus University Hospital – Psychiatry, Denmark
2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lars_meinertz_byg{at}hotmail.com
Maria Speed
1Department of Affective Disorders, Aarhus University Hospital – Psychiatry, Denmark
2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Speed
Doug Speed
3Center for Quantitative Genetics and Genomics, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Doug Speed
Søren Dinesen Østergaard
1Department of Affective Disorders, Aarhus University Hospital – Psychiatry, Denmark
2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Søren Dinesen Østergaard
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Bipolar disorder is associated with increased body mass index (BMI), but it remains undetermined if this association is causal and, if so, in which direction it goes. Here, we sought to answer these questions using bidirectional two-sample Mendelian Randomization, a method from genetic epidemiology that uses data from genome-wide association studies (GWAS) to examine whether a risk factor is causal for an outcome.

Methods We used summary statistics from GWAS of bipolar disorder and BMI conducted using data collected by the Psychiatric Genomics Consortium and the UK Biobank, respectively. The genetic instrument for bipolar disorder contained 53 SNPs and explained 0.5% of phenotypic variance, while the genetic instrument for BMI contained 517 SNPs and explained 7.1% of phenotypic variance.

Results We found that a two-fold increase in the genetic liability to bipolar disorder causes a 0.6 (kg/m2) reduction in BMI, which is statistically significant (P=0.009), and predominantly driven by reduced fat mass. Conversely, we found no evidence that BMI causes changes in the risk of developing bipolar disorder (P=0.59).

Conclusion The findings of this study indicate that the increased BMI observed among individuals with bipolar disorder is not a direct consequence of genetic liability to bipolar disorder, but more likely represents the sum of downstream correlates of manifest bipolar disorder, such as side effects of pharmacological treatment, poor diet and sedentary lifestyle, that are all modifiable and could potentially be targeted as part of clinical management.

Competing Interest Statement

SDO received the 2020 Lundbeck Foundation Young Investigator Prize. Furthermore, SDO owns units of mutual funds with stock tickers DKIGI and WEKAFKI, as well as units of exchange traded funds with stock tickers TRET, 2B76, EXH2, QDVE, QDVH, USPY, SADM and BATE. The remaining authors report no conflicts of interest.

Funding Statement

There was no specific funding for this study. SDO is supported by grants from the Novo Nordisk Foundation (grant number: NNF20SA0062874), the Lundbeck Foundation (grant numbers: R358-2020-2341 and R344-2020-1073), the Danish Cancer Society (grant number: R283-A16461), the Central Denmark Region Fund for Strengthening of Health Science (grant number: 1-36-72-4-20), the Danish Agency for Digitisation Investment Fund for New Technologies (grant number 2020-6720) and Independent Research Fund Denmark (grant number: 7016-00048B). These funders had no role in the study design, data analysis, interpretation of data, or writing of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available results from previously published GWAS, that can be downloaded from the Psychiatrics Genomics Consortium (https://www.med.unc.edu/pgc/download-results) and from the Neale Lab (http://www.nealelab.is/uk-biobank), as well as openly available genetic data from the 1000 Genomes Project (https://www.internationalgenome.org).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The GWAS summary statistics can be downloaded from the Psychiatrics Genomics Consortium (https://www.med.unc.edu/pgc/download-results) and from the Neale Lab (http://www.nealelab.is/uk-biobank). Genetic data from the 1000 Genomes Project can be downloaded from the project's website (https://www.internationalgenome.org).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 31, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genetic liability to bipolar disorder and body mass index: A bidirectional two-sample mendelian randomization study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genetic liability to bipolar disorder and body mass index: A bidirectional two-sample mendelian randomization study
Lars Meinertz Byg, Maria Speed, Doug Speed, Søren Dinesen Østergaard
medRxiv 2022.01.31.22270154; doi: https://doi.org/10.1101/2022.01.31.22270154
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genetic liability to bipolar disorder and body mass index: A bidirectional two-sample mendelian randomization study
Lars Meinertz Byg, Maria Speed, Doug Speed, Søren Dinesen Østergaard
medRxiv 2022.01.31.22270154; doi: https://doi.org/10.1101/2022.01.31.22270154

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)